CTD Holdings Inc Sample Contracts

COMMON STOCK PURCHASE WARRANT CYCLO THERAPEUTICS, INC.
Common Stock Purchase Warrant • November 21st, 2022 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received ___________, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Charter Amendment Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (1k)
AutoNDA by SimpleDocs
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • May 4th, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances)

This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 2, 2023, by and among Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), and Rafael Holdings, Inc., a Delaware corporation (“Purchaser”).

Sample 1Sample 2Sample 3See All (1k)
CONSULTING AGREEMENT AGREEMENT made this 2nd day of March, 2004, by and between Matthew Maguire., an individual, with offices at 6435 Manhattan Village Ave., #3l03, Orlando, FL 32835 (the "Consultant"), and CTD Holdings, Inc., a corporation with...
Consulting Agreement • April 15th, 2004 • CTD Holdings Inc • Medicinal chemicals & botanical products • Florida
Sample 1Sample 2Sample 3See All (989)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 3rd, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 29, 2022, between Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Sample 1Sample 2Sample 3See All (828)
RECITALS:
Employment Agreement • July 2nd, 2001 • CTD Holdings Inc • Medicinal chemicals & botanical products • Florida
Sample 1Sample 2Sample 3See All (765)
PREAMBLE
Share Exchange Agreement • August 16th, 2005 • CTD Holdings Inc • Medicinal chemicals & botanical products • Florida
Sample 1Sample 2Sample 3See All (726)
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") entered into this 1st day of July, 2009 (the "Effective Date"), between VISTRA GROWTH PARTNERS, INC. ("ViStra"), a wholly-owned subsidiary of CTD HOLDINGS, INC. (the "Company") and LOUIS...
Employment Agreement • January 19th, 2010 • CTD Holdings Inc • Industrial organic chemicals
Sample 1Sample 2Sample 3See All (619)
PRE-FUNDED COMMON STOCK PURCHASE WARRANT CYCLO THERAPEUTICS, INC.
Pre-Funded Common Stock Purchase Warrant • November 21st, 2022 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received ___________, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (439)
RECITALS:
Employment Agreement • December 1st, 2003 • CTD Holdings Inc • Medicinal chemicals & botanical products • Florida
Sample 1Sample 2Sample 3See All (327)
Warrant Agent
Warrant Agency Agreement • November 16th, 2020 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York

WARRANT AGENCY AGREEMENT, dated as of ____, 2020 (“Agreement”), between Cyclo Therapeutics, Inc., a corporation organized under the laws of the State of Nevada (the “Company”), and VStock Transfer LLC (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (272)
1,950,000 SHARES OF COMMON STOCK OF CYCLO THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Underwriting Agreement • November 19th, 2021 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York

The undersigned, Cyclo Therapeutics, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Cyclo Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

Sample 1Sample 2Sample 3See All (229)
CONSULTING AGREEMENT DATE: March 25, 2004 PARTIES: ALAN C. FERGUSON (the "Consultant") CTD HOLDINGS, INC., a Florida corporation (the "Company") AGREEMENTS: SECTION 1. RETENTION OF CONSULTANT 1.1 Effective Date. Effective March 25, 2004 (the...
Consulting Agreement • March 26th, 2004 • CTD Holdings Inc • Medicinal chemicals & botanical products • Florida
Sample 1Sample 2Sample 3See All (226)
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is effective as of May 30, 2001 (the "Effective Date") by and between CTD HOLDINGS, INC., a Florida corporation (the "Company"), and C.E. RICK STRATTAN (the "Employee"). RECITALS: This...
Employment Agreement • April 1st, 2002 • CTD Holdings Inc • Medicinal chemicals & botanical products • Florida
Sample 1Sample 2Sample 3See All (162)
Natural Spirit Mushroom Enterprise Inc., 27327 NW 78th Avenue High Springs, FL 32643
Loan Agreement • March 31st, 2000 • Cyclodextrin Technologies Development Inc • Medicinal chemicals & botanical products
Sample 1Sample 2Sample 3See All (135)
REPRESENTATIVE COMMON STOCK PURCHASE WARRANT
Common Stock Purchase Warrant • November 16th, 2020 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____3 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall be issued pursuant to that certain Underwriting Agreement, dated as of ____, 2020, by and between the Company and Maxim Group LLC, as representative of the several Underwriters named in Schedule A thereto (the “Underwriting Agreement”

Sample 1Sample 2Sample 3See All (121)
CYCLO THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Underwriting Agreement • December 11th, 2020 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York

The undersigned, Cyclo Therapeutics, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Cyclo Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

Sample 1Sample 2Sample 3See All (109)
Warrant Agent
Warrant Agency Agreement • December 11th, 2020 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York

WARRANT AGENCY AGREEMENT, dated as of December 11, 2020 (“Agreement”), between Cyclo Therapeutics, Inc., a corporation organized under the laws of the State of Nevada (the “Company”), and VStock Transfer LLC (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (92)
RECITALS:
Employment Agreement • March 30th, 2004 • CTD Holdings Inc • Medicinal chemicals & botanical products • Florida
Sample 1Sample 2Sample 3See All (80)
COMMON STOCK PURCHASE WARRANT
Common Stock Purchase Warrant • June 4th, 2019 • CTD Holdings Inc • Industrial organic chemicals

THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, ___________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 30, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ctd holdings, Inc. a Florida corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (64)
SERIES A-1 COMMON STOCK PURCHASE WARRANT CYCLO THERAPEUTICS, INC.
Security Agreement • January 3rd, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances)

THIS SERIES A-1 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 3, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), up to 2,608,696 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (53)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 4th, 2019 • CTD Holdings Inc • Industrial organic chemicals • New York

This Securities Purchase Agreement (this "Agreement") is dated as of May 30, 2019, between CTD Holdings, Inc., a Florida corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively, the "Purchasers").

Sample 1Sample 2Sample 3See All (26)
CYCLO THERAPEUTICS, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • August 16th, 2021 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York

Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:

Sample 1Sample 2Sample 3See All (19)
AutoNDA by SimpleDocs
PLACEMENT AGENCY AGREEMENT May 30, 2019
Placement Agency Agreement • June 4th, 2019 • CTD Holdings Inc • Industrial organic chemicals • New York
Sample 1Sample 2Sample 3See All (9)
FIFTH AMENDED AND RESTATED NOTE PURCHASE AGREEMENT
Note Purchase Agreement • November 8th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

THIS FIFTH AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of November 7, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).

Sample 1Sample 2Sample 3See All (8)
VOTING AGREEMENT
Voting Agreement • September 21st, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

This Voting Agreement (this “Voting Agreement”) is being delivered on September [•], 2023 by the person or persons named on the signature pages hereto (collectively, the “Holder”), as the holder of Company Shares (as defined below) of Applied Molecular Transport Inc., a Delaware corporation (the “Company”), to Cyclo Therapeutics, Inc., a Nevada corporation (“Parent”).

Sample 1Sample 2Sample 3See All (5)
EMPLOYMENT AGREEMENT
Employment Agreement • February 2nd, 2011 • CTD Holdings Inc • Industrial organic chemicals • Florida

THIS EMPLOYMENT AGREEMENT (the "Agreement") is effective as of January 1, 2008, (the "Effective Date") by and between CTD HOLDINGS, INC., a Florida corporation (the "Company"), and C.E. RICK STRATTAN (the "Employee").

Sample 1Sample 2Sample 3See All (5)
FORM OF LOCK-UP AGREEMENT
Lock-Up Agreement • August 22nd, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Sample 1Sample 2Sample 3See All (4)
CYCLO THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 4th, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Florida

This Securities Purchase Agreement (this “Agreement”) is made and entered into as of May 2, 2023, by and among Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), and Rafael Holdings, Inc., a Delaware corporation (“Purchaser”).

Sample 1Sample 2Sample 3See All (4)
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
Merger Agreement • September 21st, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances)

GAINESVILLE, FL and SOUTH SAN FRANCISCO, CA – (Businesswire) – September 21, 2023 – Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company focused on developing transformative therapies for rare and neurological diseases with limited treatment options, and Applied Molecular Transport Inc. (Nasdaq: AMTI) (“AMT”), a biopharmaceutical company, announced today that the companies have entered into a definitive agreement (the Merger Agreement) pursuant to which AMT will merge with Cyclo Therapeutics in an all-stock transaction (the Merger). Following the closing of the Merger, the combined company will operate under the name “Cyclo Therapeutics, Inc.” and will continue trading on The Nasdaq Capital Market under the ticker symbol “CYTH”. The combined company will focus on advancing Cyclo Therapeutics’ pivotal Phase 3 global study (TransportNPC™) evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 (NPC1). The transaction

Sample 1Sample 2Sample 3See All (4)
EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • March 2nd, 2022 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • Florida

THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), is made as of the 28th day of February, 2022 (the “Effective Date”), by and between Cyclo Therapeutics Inc., a Nevada corporation with its principal place of business at 6714 NW 16th Street, Suite B, Gainesville, FL 32653 (together with its subsidiaries, the “Company") and Michael Lisjak (the “Executive”) (collectively, the “Parties”).

Sample 1Sample 2Sample 3See All (4)
AGREEMENT AND PLAN OF MERGER
Merger Agreement • August 22nd, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Nevada

THIS AGREEMENT AND PLAN OF MERGER (as may be amended from time to time, this “Agreement”) is made and entered into as of August 21, 2024, by and among: Rafael Holdings, Inc., a Delaware corporation (“Parent”); Tandem Therapeutics, Inc., a Nevada corporation and a wholly-owned subsidiary of Parent (“First Merger Sub”); Tandem Therapeutics, LLC, a Nevada limited liability company and a wholly-owned subsidiary of Parent (“Second Merger Sub”, and together with First Merger Sub, “Merger Subs”); and Cyclo Therapeutics, Inc, a Nevada corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

Sample 1Sample 2Sample 3
FORM OF SUPPORT AGREEMENT
Support Agreement • August 22nd, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

This SUPPORT AGREEMENT (this “Agreement”), dated as of [ ], 2024, is made and entered into by and among Howard Jonas, and individual (“Holder”), Rafael Holdings, Inc., a Delaware corporation (“Rafael”) and Cyclo Therapeutics, Inc., a Nevada corporation (“Cyclo”). Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Merger Agreement (as defined below).

Sample 1Sample 2Sample 3
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT CYCLO THERAPEUTICS, INC.
Securities Agreement • January 3rd, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances)

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December 29, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of December 18, 2022.

Sample 1Sample 2Sample 3
FORM OF VOTING AGREEMENT
Voting Agreement • August 22nd, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Nevada

THIS VOTING AGREEMENT, dated as of [ ], 2024 (this “Agreement”), is between Rafael Holdings, Inc., a Delaware corporation (“Rafael”), and the undersigned (the “Stockholder”).

Sample 1Sample 2
GUARANTY (Continuing Debt – Unlimited)
Guaranty • March 28th, 2011 • CTD Holdings Inc • Industrial organic chemicals • Florida
Sample 1Sample 2
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!